Membranous nephropathy: Treatment outline and risk stratification

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Arabi, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697423/
https://www.ncbi.nlm.nih.gov/pubmed/23826548
http://dx.doi.org/10.4103/2231-0770.102278
_version_ 1782275198419992576
author Arabi, Ziad
author_facet Arabi, Ziad
author_sort Arabi, Ziad
collection PubMed
description Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy based on a careful risk-stratification approach.
format Online
Article
Text
id pubmed-3697423
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36974232013-07-03 Membranous nephropathy: Treatment outline and risk stratification Arabi, Ziad Avicenna J Med Review Article Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy based on a careful risk-stratification approach. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3697423/ /pubmed/23826548 http://dx.doi.org/10.4103/2231-0770.102278 Text en Copyright: © Avicenna Journal of Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Arabi, Ziad
Membranous nephropathy: Treatment outline and risk stratification
title Membranous nephropathy: Treatment outline and risk stratification
title_full Membranous nephropathy: Treatment outline and risk stratification
title_fullStr Membranous nephropathy: Treatment outline and risk stratification
title_full_unstemmed Membranous nephropathy: Treatment outline and risk stratification
title_short Membranous nephropathy: Treatment outline and risk stratification
title_sort membranous nephropathy: treatment outline and risk stratification
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697423/
https://www.ncbi.nlm.nih.gov/pubmed/23826548
http://dx.doi.org/10.4103/2231-0770.102278
work_keys_str_mv AT arabiziad membranousnephropathytreatmentoutlineandriskstratification

Ejemplares similares